Meng J - Search Results

1

Peripheral lymphocyte subset variation predicts prostate cancer carbon ion radiotherapy outcomes.

Yang ZR, Zhao N, Meng J, Shi ZL, Li BX, Wu XW, Li P, Zhang Q, Wei XB, Fu S. Yang ZR, et al. Among authors: meng j. Oncotarget. 2016 May 3;7(18):26422-35. doi: 10.18632/oncotarget.8389. Oncotarget. 2016. PMID: 27029063 Free PMC article. Clinical Trial.

2

A radiosensitivity gene signature in predicting glioma prognostic via EMT pathway.

Meng J, Li P, Zhang Q, Yang Z, Fu S. Meng J, et al. Oncotarget. 2014 Jul 15;5(13):4683-93. doi: 10.18632/oncotarget.2088. Oncotarget. 2014. PMID: 24970813 Free PMC article.

3

A four-long non-coding RNA signature in predicting breast cancer survival.

Meng J, Li P, Zhang Q, Yang Z, Fu S. Meng J, et al. J Exp Clin Cancer Res. 2014 Oct 6;33(1):84. doi: 10.1186/s13046-014-0084-7. J Exp Clin Cancer Res. 2014. PMID: 25288503 Free PMC article.

4

RGD-conjugated mesoporous silica-encapsulated gold nanorods enhance the sensitization of triple-negative breast cancer to megavoltage radiation therapy.

Zhao N, Yang Z, Li B, Meng J, Shi Z, Li P, Fu S. Zhao N, et al. Among authors: meng j. Int J Nanomedicine. 2016 Oct 27;11:5595-5610. doi: 10.2147/IJN.S104034. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27822038 Free PMC article.

5

Prognostic value of an immunohistochemical signature in patients with esophageal squamous cell carcinoma undergoing radical esophagectomy.

Meng J, Zhang J, Xiu Y, Jin Y, Xiang J, Nie Y, Fu S, Zhao K. Meng J, et al. Mol Oncol. 2018 Feb;12(2):196-207. doi: 10.1002/1878-0261.12158. Epub 2018 Jan 6. Mol Oncol. 2018. PMID: 29160958 Free PMC article.

6

Radiomics-based machine learning methods for isocitrate dehydrogenase genotype prediction of diffuse gliomas.

Wu S, Meng J, Yu Q, Li P, Fu S. Wu S, et al. Among authors: meng j. J Cancer Res Clin Oncol. 2019 Mar;145(3):543-550. doi: 10.1007/s00432-018-2787-1. Epub 2019 Feb 4. J Cancer Res Clin Oncol. 2019. PMID: 30719536 Free PMC article.

7

CXCR6 expression correlates with radiotherapy response and immune context in triple-negative breast cancer-experimental studies.

Meng J, Yang Y, Lv J, Lv H, Zhao X, Zhang L, Shi W, Yang Z, Mei X, Chen X, Ma J, Zhang Z, Shao Z, Yu X, Guo X. Meng J, et al. Int J Surg. 2024 Aug 1;110(8):4695-4707. doi: 10.1097/JS9.0000000000001546. Int J Surg. 2024. PMID: 39143706 Free PMC article.

8

Adjuvant breast inversely planned intensity-modulated radiotherapy with simultaneous integrated boost for early stage breast cancer : Results from a phase II trial.

Meng J, Huang W, Mei X, Yu X, Pan Z, Ma J, Ma X, Chen J, Guo X, Yang Z. Meng J, et al. Strahlenther Onkol. 2020 Sep;196(9):764-770. doi: 10.1007/s00066-020-01611-1. Epub 2020 Apr 21. Strahlenther Onkol. 2020. PMID: 32318767 Clinical Trial. English.

9

The Role of Radiotherapy for Patients with Unresectable Locally Advanced Breast Cancer following Neoadjuvant Systemic Therapy.

Wang X, Meng J, Zhang X, Zhang L, Chen X, Yang Z, Mei X, Yu X, Zhang Z, Shao Z, Liu G, Guo X, Ma J. Wang X, et al. Among authors: meng j. J Oncol. 2023 Feb 17;2023:5101078. doi: 10.1155/2023/5101078. eCollection 2023. J Oncol. 2023. PMID: 36844867 Free PMC article.

10

Brain Radiotherapy With Pyrotinib and Capecitabine in Patients With ERBB2-Positive Advanced Breast Cancer and Brain Metastases: A Nonrandomized Phase 2 Trial.

Yang Z, Meng J, Mei X, Mo M, Xiao Q, Han X, Zhang L, Shi W, Chen X, Ma J, Palmer J, Shao Z, Zhang Z, Yu X, Guo X. Yang Z, et al. Among authors: meng j. JAMA Oncol. 2024 Mar 1;10(3):335-341. doi: 10.1001/jamaoncol.2023.5791. JAMA Oncol. 2024. PMID: 38175627 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,279 results

Search Page

Filters